Estimation of the average hazard ratio
From MaRDI portal
Cited in
(37)- A practical divergence measure for survival distributions that can be estimated from Kaplan-Meier curves
- Modified spline regression based on randomly right-censored data: A comparative study
- Empirical likelihood for cumulative hazard ratio estimation with covariate adjustment
- A novel stratified analysis method for testing and estimating overall treatment effects on time-to-event outcomes using average hazard with survival weight
- Using win odds to improve commit-to-phase-3 decision-making in oncology
- A comparison of statistical methods for time-to-event analyses in randomized controlled trials under non-proportional hazards
- Inference for the Proportional Hazards Model with Misclassified Discrete-Valued Covariates
- Non-parametric testing of non-inferiority with censored data
- Oncology clinical trial design planning based on a multistate model that jointly models progression-free and overall survival endpoints
- Improving testing and description of treatment effect in clinical trials with survival outcomes
- Extremes of censored and uncensored lifetimes in survival data
- Nonparametric adaptive enrichment designs using categorical surrogate data
- Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical study
- Effectively Selecting a Target Population for a Future Comparative Study
- Sequential tests for non-proportional hazards data
- BAGS: a Bayesian adaptive group sequential trial design with subgroup-specific survival comparisons
- Estimation of odds of concordance based on the Aalen additive model
- Quantifying the average of the time-varying hazard ratio via a class of transformations
- Ratio and difference of average hazard with survival weight: new measures to quantify survival benefit of new therapy
- RMST-based multiple contrast tests in general factorial designs
- Analysis of survival data with nonproportional hazards: a comparison of propensity-score-weighted methods
- Nonparametric analysis of delayed treatment effects using single-crossing constraints
- Effect of a correlated competing risk on marginal survival estimation in an accelerated failure time model
- Estimates of relative risk
- Design of phase III trials with long-term survival outcomes based on short-term binary results
- Cox (1972): recollections and reflections
- Sample size calculation under nonproportional hazards using average hazard ratios
- Assessing delayed treatment benefits of immunotherapy using long-term average hazard: a novel test/estimation approach
- Assessing potentially time-dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial
- Non-parametric estimators of hazard ratios for comparing two survival curves
- Regression models for average hazard
- Inference for cumulative incidences and treatment effects in randomized controlled trials with time-to-event outcomes under ICH E9 (R1)
- A rank estimator in the two-sample transformation model with randomly censored data
- Estimating Cumulative Treatment Effects in the Presence of Nonproportional Hazards
- A Note on the Estimate of Treatment Effect from a Cox Regression Model When the Proportionality Assumption Is Violated
- Estimating cumulative treatment effect under an additive hazards model
- Intention-to-treat comparisons in randomized trials
This page was built for publication: Estimation of the average hazard ratio
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3925716)
